Does acute promyelocytic leukemia in Indian patients have biology different from the West?

Indian Journal of Pathology and Microbiology

Volumn 51, Issue 3, 2008, Pages 437-439

  Dutta, Pankhi ^a   Sazawal, Sudha ^a   Kumar, Rajat ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute promyelocytic leukemia; Biology; India; Reverse transcriptase PCR

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOCHEMISTRY; DISEASE COURSE; FEMALE; HUMAN; INDIAN; LABORATORY TEST; MALE; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEX RATIO;

ADULT; AZO COMPOUNDS; BLOOD CELLS; BONE MARROW; CHILD; ESTERASES; FEMALE; HUMANS; INDIA; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 50149084340     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.42555     Document Type: Article

References (10)

1. th ed. Churchill Livingstone; 2001. p. 269-95.
2. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Froretos T, et al. Diagnosis of acute promyelocytic leukemia by RT-PCR: Detection of PML-RARA and RARA_PML fusion transcripts. Br J Haematol 1992;82:529-40.
3. th ed. vol 2. Lippincott Williams and Wilkins; 2004. p. 2191-206.
4. Liso V, Troccoli G, Grande M. Cytochemical study of acute promyelocytic leukaemia, Nat Band 1975;30:261-8.
5. Das Gupta A, Sapre RS, Shah AS, Advani SH, Nair CN. Cytochemical and immunophenotypic heterogeneity in acute promyelocytic leukemia. Acta Haematol 1989;81:5-9.
6. Sazawal S, Hasan SK, Dutta P, Kumar B, Kumar R, Kumar L, et al. Over-representation of bcr3 subtype of PML-RARalpha fusion gene in APL in Indian patients. Ann Hematol 2005;84:781-4.
7. Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, et al. Establishing the presence of the (15:17) in suspected acute promyelocytic leukaemia: Cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the MRC ATRA trial. Br J Haematol 1996;94:557-73.
8. Douer D, Santillana S, Ramezani L, Samanez C, Slovak ML, Lee MS, et al. Acute promyelocytic leukaemia in patients originating in Latin America is associated with an associated frequency of the bcr1 subtype of the PML-RARα fusion gene. Br J Haematol 2003;122:563-70.
9. Lo-Coco F, Breccia M, Diverio D. The importance of molecular monitoring in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003;16:503-20.
10. Gonzalez M, Barragan E, Bolufer P, Chillón C, Colomer D, Borstein R, et al. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARA isoforms: A study of the PETHEMA group. Br J Haematol 2001;114:99-103.